Skip to content

AS Orthana® versus Biotène Oralbalance® for patients with dry mouth

Comparative study to evaluate effectiveness of mucin saliva product AS Orthana® versus Biotène Oralbalance® Gel for patients with dry mouth

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN71177327
Enrollment
30
Registered
2012-10-16
Start date
2012-10-12
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry mouth / xerostomia Digestive System Xerostomia

Interventions

Participants will be patients under the care of the Oral Maxillofacial Surgery Department who have dry mouth. Information about the study will be given to patients who meet the inclusion criteria, the

Sponsors

Pennine Acute Hospitals NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who are referred to the Oral Maxillofacial Surgery Department at North Manchester General Hospital with dry mouth / xerostomia 2. Patients whom clinicians have advised to use an artificial saliva product 3. Patients aged 18 years and over from of either gender 4. Patients must be able to communicate in English

Exclusion criteria

Exclusion criteria: 1. Patients who lack the capacity to consent to participation in the study 2. Patients below 18 years old 3. Patients who are unable communicate in English 4. Patients who are felt to be in the last hours or days of life (i.e. on the Liverpool Pathway for Care of the Dying Patient - LCP) 5. Patients involved in another current research

Design outcomes

Primary

MeasureTime frame
1. Improvement of patient symptoms reflected by VAS 2. The Summated Xerostomia Inventory Questionnaire At baseline, after 5 days from start of the first product and after 5 days from the start of second product.

Secondary

MeasureTime frame
Patient preference for one of the two products measured after 5 days from the start of second product

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026